Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline <i>RET</i> Proto-Oncogene Mutations

12 Mar 2014

Abstract excerpt

BACKGROUND: Age-related risk of medullary thyroid carcinoma (MTC) development in presymptomatic carriers of lower risk germline RET mutations is uncertain; such data may aid counseling patients regarding timing of thyroidectomy. METHODS: From an institutional database and an exhaustive literature review, we identified 679 patients with American Thyroid Association (ATA) level A or B mutations who were identified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Thyroid and Parathyroid Surgery
Share to Thyroid Cancer Diagnosis and Treatment
Share to Thyroid Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24617864
DOI: 10.1089/thy.2013.0620

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline <i>RET</i> Proto-Oncogene MutationsPMID 24617864Read ↗

Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.Semantic proximity Read ↗

Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma.Semantic proximity Read ↗

Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RETSemantic proximity Read ↗

Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791.Semantic proximity Read ↗

RET proto oncogene mutation detection and medullary thyroid carcinoma prevention.Semantic proximity Read ↗

Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency.Semantic proximity Read ↗

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.Semantic proximity Read ↗

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double <i>RET</i> mutationsSemantic proximity Read ↗

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.Semantic proximity Read ↗

2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid CancerSemantic proximity Read ↗

The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma -- only phenotype with incomplete penetrance: implications for screening and management of carrier status.Semantic proximity Read ↗

p.Val804Met, the Most Frequent Pathogenic Mutation in RET, Confers a Very Low Lifetime Risk of Medullary Thyroid Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.